452 related articles for article (PubMed ID: 30755367)
41. Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda.
Kimbugwe G; Vatrinet R; Mwanga JA; Kakuru R; Mpeirwe D; Logoose S; Opio K; Kambale M; Seeley J; Grais RF; Marquer C; Kaleebu P; Ssali A
Vaccine; 2024 Apr; 42(12):3002-3008. PubMed ID: 38565464
[TBL] [Abstract][Full Text] [Related]
42. EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country.
Mooney T; Smout E; Leigh B; Greenwood B; Enria L; Ishola D; Manno D; Samai M; Douoguih M; Watson-Jones D
Clin Trials; 2018 Oct; 15(5):436-443. PubMed ID: 29895178
[TBL] [Abstract][Full Text] [Related]
43. Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone.
Enria L; Lees S; Smout E; Mooney T; Tengbeh AF; Leigh B; Greenwood B; Watson-Jones D; Larson H
BMC Public Health; 2016 Nov; 16(1):1140. PubMed ID: 27821112
[TBL] [Abstract][Full Text] [Related]
44. A community's experience during and after the Ebola epidemic of 2014-2016 in Sierra Leone: A qualitative study.
Murray RT; Drew LB; Memmott C; Bangura YM; Maring EF
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009203. PubMed ID: 33630847
[TBL] [Abstract][Full Text] [Related]
45. Agent-Based Modeling and Simulation of Nosocomial Infection among Healthcare Workers during Ebola Virus Disease Outbreak in Sierra Leone.
Jones-Konneh TEC; Suda T; Sasaki H; Egawa S
Tohoku J Exp Med; 2018 Aug; 245(4):231-238. PubMed ID: 30078788
[TBL] [Abstract][Full Text] [Related]
46. Lessons Learned in Clinical Trial Communication During an Ebola Outbreak: The Implementation of STRIVE.
Callis A; Carter VM; Ramakrishnan A; Albert AP; Conteh L; Barrie AA; Fahnbulleh L; Koroma MM; Saidu S; Williams O; Samai M
J Infect Dis; 2018 May; 217(suppl_1):S40-S47. PubMed ID: 29788341
[TBL] [Abstract][Full Text] [Related]
47. Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey.
Irwin KL; Jalloh MF; Corker J; Alpha Mahmoud B; Robinson SJ; Li W; James NE; Sellu M; Jalloh MB; Diallo AA; Tracy L; Hajjeh R; VanSteelandt A; Bunnell R; Martel L; Raghunathan PL; Marston B;
Vaccine; 2017 Dec; 35(49 Pt B):6915-6923. PubMed ID: 28716555
[TBL] [Abstract][Full Text] [Related]
48. Providing healthcare to Ebola survivors: A qualitative exploratory investigation of healthcare providers' views and experiences in Sierra Leone.
James PB; Wardle J; Steel A; Adams J; Bah AJ; Sevalie S
Glob Public Health; 2020 Sep; 15(9):1380-1395. PubMed ID: 32379008
[TBL] [Abstract][Full Text] [Related]
49. Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model.
Diakite I; Mooring EQ; Velásquez GE; Murray MB
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004866. PubMed ID: 27509037
[TBL] [Abstract][Full Text] [Related]
50. Impact of the Ebola outbreak on routine immunization in western area, Sierra Leone - a field survey from an Ebola epidemic area.
Sun X; Samba TT; Yao J; Yin W; Xiao L; Liu F; Liu X; Zhou J; Kou Z; Fan H; Zhang H; Williams A; Lansana PM; Yin Z
BMC Public Health; 2017 Apr; 17(1):363. PubMed ID: 28446173
[TBL] [Abstract][Full Text] [Related]
51. The healthcare workers' clinical skill set requirements for a uniformed international response to the Ebola virus disease outbreak in West Africa: the Canadian perspective.
Marion D; Charlebois PB; Kao R
J R Army Med Corps; 2016 Jun; 162(3):207-11. PubMed ID: 26987351
[TBL] [Abstract][Full Text] [Related]
52. The potential impact of a prophylactic vaccine for Ebola in Sierra Leone.
Bodine EN; Cook C; Shorten M
Math Biosci Eng; 2018 Apr; 15(2):337-359. PubMed ID: 29161839
[TBL] [Abstract][Full Text] [Related]
53. A practical community-based response strategy to interrupt Ebola transmission in sierra Leone, 2014-2015.
Li ZJ; Tu WX; Wang XC; Shi GQ; Yin ZD; Su HJ; Shen T; Zhang DP; Li JD; Lv S; Cao CL; Xie RQ; Lu HZ; Jiang RM; Cao Z; An ZJ; Li LL; Xu J; Xiong YW; Zang W; Zhang W; Zhang HW; Chen WS; Ling H; Xu W; Cai J; Luo HJ; Xing XS; Zheng CJ; Wei Q; Li XX; Li M; Jiang H; Deng LQ; Chen MQ; Huo X; Xu F; Lai XH; Bai XC; Ye LJ; Yao JY; Yin WW; Sun JJ; Xiao L; Liu FQ; Liu XQ; Fan HW; Kou ZQ; Zhou JK; Zhang H; Ni DX; Samba TT; Li Q; Yu HJ; Wang Y; Liang XF
Infect Dis Poverty; 2016 Aug; 5(1):74. PubMed ID: 27491387
[TBL] [Abstract][Full Text] [Related]
54. Public Confidence in the Health Care System 1 Year After the Start of the Ebola Virus Disease Outbreak - Sierra Leone, July 2015.
Li W; Jalloh MF; Bunnell R; Aki-Sawyerr Y; Conteh L; Sengeh P; Redd JT; Hersey S; Morgan O; Jalloh MB; O'Leary A; Burdette E; Hageman K
MMWR Morb Mortal Wkly Rep; 2016 Jun; 65(21):538-42. PubMed ID: 27254016
[TBL] [Abstract][Full Text] [Related]
55. Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone.
Camacho A; Eggo RM; Goeyvaerts N; Vandebosch A; Mogg R; Funk S; Kucharski AJ; Watson CH; Vangeneugden T; Edmunds WJ
Vaccine; 2017 Jan; 35(4):544-551. PubMed ID: 28024952
[TBL] [Abstract][Full Text] [Related]
56. Staffing in public health facilities after the Ebola outbreak in rural Sierra Leone: How much has changed?
Squire JS; Hann K; Denisiuk O; Zachariah R
F1000Res; 2019; 8():793. PubMed ID: 32148756
[No Abstract] [Full Text] [Related]
57. Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo.
Potluri R; Kumar A; Oriol-Mathieu V; Van Effelterre T; Metz L; Bhandari H
BMC Infect Dis; 2022 Oct; 22(1):769. PubMed ID: 36192683
[TBL] [Abstract][Full Text] [Related]
58. Notes from the Field: Ebola Virus Disease Response Activities During a Mass Displacement Event After Flooding--Freetown, Sierra Leone, September-November, 2015.
Ratto J; Ivy W; Purfield A; Bangura J; Omoko A; Boateng I; Duffy N; Sims G; Beamer B; Pi-Sunyer T; Kamara S; Conteh S; Redd J
MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):188-9. PubMed ID: 26914633
[TBL] [Abstract][Full Text] [Related]
59. Are malaria transmission-blocking vaccines acceptable to high burden communities? Results from a mixed methods study in Bo, Sierra Leone.
McCoy KD; Weldon CT; Ansumana R; Lamin JM; Stenger DA; Ryan SJ; Bardosh K; Jacobsen KH; Dinglasan RR
Malar J; 2021 Apr; 20(1):183. PubMed ID: 33849572
[TBL] [Abstract][Full Text] [Related]
60. Revitalization of integrated disease surveillance and response in Sierra Leone post Ebola virus disease outbreak.
Njuguna C; Jambai A; Chimbaru A; Nordstrom A; Conteh R; Latt A; O-Tipo S; Musoke R; Githuku J; Yoti Z; Yahaya A; Talisuna A; Rajatonirina S; Fall IS
BMC Public Health; 2019 Apr; 19(1):364. PubMed ID: 30940125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
